GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE84188 Query DataSets for GSE84188
Status Public on Dec 31, 2016
Title Ebolavirus species associated with differential pathogenicity induce distinct host responses in human macrophages
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Highly pathogenic Zaire ebolavirus (EBOV) infection is associated with a dysregulated immune response and high levels of cytokines and chemokines are observed in fatal human cases. . In stark contrast Reston ebolavirus (RESTV) might be non-pathogenic for humans yet the underlying mechanisms determining pathogenicity for different Ebola viruses are not understood. In this study we investigate antiviral immune responses in EBOV- and RESTV- infected primary human monocyte-derived macrophages (MDM). We provide evidence that increased pathogenicity of the highly pathogenic EBOV is associated with a strong activation of host responses from infected MDM. The observed cytokine response after EBOV infection is strikingly similar to LPS-mediated immune signatures however EBOV caused significant induction of the interferon response in addition. In contrast we show that the low pathogenic RESTV fails to elicit significant immune responses in infected MDM. These results demonstrate a correlation of pathogenicity and excessive MDM activation for different Ebola virus species. Interaction of the viral glycoprotein (GP) with Toll-like receptor 4 (TLR4) leading to activation of NF_B signaling is responsible for this effect rather than differences in replication or blocking of immune signaling. We demonstrate that inhibition of TLR4 is able to abolish EBOV-GP mediated NF_B activation which might offer the possibility to develop targeted treatments for EBOV limiting the extreme immune response that seems to be detrimental to the host.
Overall design RNA was isolated from primary cultured human macrophages (n=3 donors) that were either mock-infected, infected with Ebola virus (Kikwit-95) or Reston virus (Pennsylvania), or treated with lipopolysaccharide (LPS).
Contributor(s) Olejnik J, Forero A, Rasmussen AL, Mühlberger E
Citation(s) 28331091
NIH grant(s)
Grant ID Grant title Affiliation Name
U01 AI082954 Early Host Immune Response in Protection Against Filovirus Infection BOSTON UNIVERSITY MUEHLBERGER
U19 AI109761 Systems Biology Approaches to Molecular Diagnostics and Antiviral Drug Targeting UNIVERSITY OF WASHINGTON KATZE
R03 AI114293 Filovirus replication: initiation mechanism and role of RNA secondary structures BOSTON UNIVERSITY MUEHLBERGER
UC6 AI058618 National Center/Emerging Infectous Diseases & Biodefense BOSTON UNIVERSITY MURPHY
Submission date Jul 08, 2016
Last update date May 15, 2019
Contact name Angela Rasmussen
Organization name Columbia University
Department Center for Infection and Immunity
Street address 722 W. 168th St
City New York
State/province NY
ZIP/Postal code 10032
Country USA
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (42)
GSM2228762 Donor9_MOCK_6H
GSM2228763 Donor9_LPS_6H
GSM2228764 Donor9_EBOV_6H
BioProject PRJNA328248
SRA SRP078152

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE84188_masterDE_withrestim_corrected.csv.gz 7.8 Mb (ftp)(http) CSV
GSE84188_norm_matrix_corrected.txt.gz 987.1 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap